Joseph Pitts said...
I am particularly interested in how the process can be better utilized for rare diseases.
Context
Pitts expresses interest in improving drug approval for rare diseases.
03/07/2012
Pitts expresses interest in improving drug approval for rare diseases.
03/07/2012